Chargement en cours...
Update on PD-1/PD-L1 Inhibitors in Multiple Myeloma
The treatment of cancer, especially of various types of solid tumors, has been revolutionized by the blockade of the PD-1/PD-L1 pathway by immune checkpoint inhibitors. Their success amongst hematologic malignancies, however, has been limited so far to the treatment of classic Hodgkin's lymphom...
Enregistré dans:
| Publié dans: | Front Immunol |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6250817/ https://ncbi.nlm.nih.gov/pubmed/30505301 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.02431 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|